Industry News

Primary Care Physicians to Drive Growth in Handheld Ultrasound Market

By Medimaging International staff writers
08 May 2019

Image: The Vscan portable handheld ultrasound (Photo courtesy of GE Healthcare).The global market for handheld ultrasound is projected to surpass USD 400 million by 2023. In 2018, sales of handheld ultrasound accounted for less than 2% of the USD 6.9 billion global ultrasound equipment market, with the relatively high cost and limited performance of early generation handhelds limiting growth. However, over the years, there has been a consistent improvement in products, accompanied by innovations by new market entrants, thereby unlocking the full value of handheld ultrasound for experienced as well as new users. An expanding customer base, coupled with increased availability of affordable handheld scanners, is expected to boost the global sales of handheld ultrasound by over 50% in 2019.

These are the latest findings of Signify Research (Cranfield, UK), an independent supplier of market intelligence and consultancy to the global healthcare technology industry.

Handheld ultrasound has gained some acceptance in procedural ultrasound, including vascular access and anesthesia, and more recently among MSK specialists who have begun using it for in-office exams, intra-operative imaging and in-field medicine. In 2018, emergency medicine was the largest market for handheld ultrasound and was worth around USD 15 million, but represented only 10% of the total ultrasound system sales, with compact and cart-based systems accounting for a majority of the market share. Over the coming years, handhelds are expected to gain market share while compact systems and, to a lesser extent, cart-based systems are likely to remain the preferred form factors.

The increasing use of handheld ultrasound in traditional point-of-care ultrasound (POCUS) markets is being further boosted by office-based physicians in various medical specialities, such as urology, gastroenterology and vascular. In-office specialists are using handheld ultrasound for quick exams and initial screening, usually as an adjunct to the more powerful cart-based systems in their hospital departments.

Primary care remains a largely untapped market for handheld ultrasound and is potentially the largest opportunity. Currently, the use of handheld ultrasound in primary care is limited mainly to rural areas, initially in the developed countries and more recently in low- and middle-income countries. Handheld ultrasound is playing an essential role in low- and middle-income countries in expanding patient access to medical imaging, with cardiac screening, pregnancy screening and diagnosis of respiratory and abdominal complaints being some of the main uses. Moreover, over the last couple of years, the price of handheld scanners has declined significantly, making them a cost-effective option for most primary care physicians. Going forward, the uptake of handheld ultrasound in urban primary care is expected to increase, initially in the developed markets such as the U.S, Japan and Western Europe.

However, most primary care physicians lack formal ultrasound training and reimbursement is not widely available. General practitioners in several European countries are required to be certified to receive reimbursement for performing ultrasound scans. In order to address the lack of skills, vendors of handheld scanners are making efforts to simplify ease-of-use in terms of the device as well as through integrated tele-ultrasound services that connect novice users with experts at separate locations over two-way audio and video calls. The latest generation of handheld scanners features several presets for common exam types, and also applies artificial intelligence (AI) to enable physicians without any prior scanning experience to capture high quality images. AI-guided ultrasound helps users to identify body parts and correctly position the transducer for maximizing the image quality during exams.

Presently, the use of AI in ultrasound is at an early stage and AI solutions with broader functionality that can support the detection and diagnosis of multiple conditions for a body area are expected in the near future. Similarly, the first handheld scanners with AI for providing support during the image acquisition process are expected to launch over the next year or two. The advent of smart devices with AI for both image acquisition and interpretation will drive the widespread use of handheld ultrasound in primary as well as multiple other care settings. Going forward, AI is expected to play an increasingly important role in image interpretation by providing physicians with automated measurements, anomaly detection and diagnostic decision support.

However, the global market for handheld ultrasound faces some key challenges, such as limited reimbursement in most countries, credentialing, data security and quality assurance (both for image capture and interpretation). Additionally, although handheld ultrasound devices are ready for mainstream adoption, several institutions lack the IT infrastructure required to provide seamless patient care between office and hospital settings. These challenges need to be properly addressed and overcome in order for handheld ultrasound to realize its full potential.

Related Links:
Signify Research



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

30 May 2020
MEDICAL FAIR ASIA 2020 Set to Take Place in Singapore from 9-11 December 2020
MEDICAL FAIR ASIA 2020 is set to take place in Singapore from 9-11 December 2020 at Marina Bay Sands, with the exhibition featuring the latest medical technology and innovations, and healthcare equipment and supplies.
Read More
20 Apr 2020
Nova's Stat EMS Basic Blood Testing System Launched in CE Mark Countries
Nova Biomedical (Waltham, MA, USA) has launched the Stat EMS Basic blood testing system for ambulance and emergency care in CE mark countries. Stat EMS Basic measures fingerstick capillary lactate, glucose, ketone, hemoglobin, and hematocrit in six to 40 seconds with laboratory-quality results.
Read More
20 Apr 2020
Nova's Stat Profile Prime Plus Blood Gas Analyzer Receives FDA Clearance for POC Use
Nova Biomedical (Waltham, MA, USA) has secured clearance from the US Food and Drug Administration (FDA) for its Stat Profile Prime Plus critical care blood gas analyzer for point-of-care (POC) use.
Read More
17 Apr 2020
ECR 2020 to Go Ahead as Online Congress on July 15-19, 2020
In view of the ongoing spread of COVID-19 across the world and its growing global impact, the board of directors of the European Society of Radiology (Vienna) has decided not to hold an onsite European Congress of Radiology (ECR) in 2020. Instead, ECR 2020 will go ahead as an online congress to ensure a safe experience for its members, partners, staff and the general public.
Read More
08 Apr 2020
Nova Biomedical Adds PT/INR Test to Allegro Analyzer for POC Testing
Nova Biomedical (Waltham, MA, USA) has added PT/INR testing for its Allegro capillary blood analyzer for point-of-care (POC) testing in primary care settings. With the ability to test for clotting disorders and monitor the effectiveness of blood-thinning medications, the Allegro and its StatStrip-A companion meter provide 18 clinically important tests to help physicians make therapeutic decisions and adjustments at the POC.
Read More
01 Apr 2020
SymphonyAI Acquires TeraRecon
SymphonyAI Group (Los Altos, CA, USA), an operating group of leading business-to-business artificial intelligence (AI) companies, has acquired TeraRecon (Durham, NC, USA), an advanced visualization and AI solution provider for medical imaging.
Read More
23 Mar 2020
Artificial Intelligence-Based Methods to Cut MRI Read Times Receives USD 250K Grant
 Research to detect and predict blocked arteries and cardiovascular risk using knee MRI images conducted by Chun Yuan, Ph.D., Professor of Radiology and Bioengineering and Vice Chair for Global Affairs at the University of Washington (Seattle, WA, USA) has been recognized and awarded a grant by the American Heart Association’s (AHA) Institute for Precision Cardiovascular Medicine (Dallas, TX, USA).
Read More
23 Mar 2020
Surgical Robots Market to Reach USD 13.1 Billion by 2027 Due to High Acceptance in Emerging Regions
 The global surgical robots market is forecasted to reach USD 13.1 billion by 2027, driven mainly by low turn-around times and increased innovation in robotics over the coming years. Surgical robots are finding increased acceptance in the emerging Asia region, according to a study by Transparency Market Research (Albany NY, USA), a next-generation market intelligence provider. The study is based on recent findings by IEEE (an Association for Electronic Engineering) that millennial parents are increasingly opting for robotic surgeries for their children in Asia Pacific region. The study also reveals that low availability of robotic surgeries remains a concern.
Read More
19 Mar 2020
Advantech Launches Medical-Grade AVAS-400 Series 4K UHD Video Recorder
 Advantech Co., Ltd. (Taipei, Taiwan), a provider of medical computing platforms and solutions, has launched its AVAS-400 Series medical-grade 4K ultra high-definition (UHD) video recorder aimed at ensuring operating precision. Advantech’s AVAS-400 Series, which includes two models, the AVAS-401 and the AVAS-402, are ideal for surgery centers, operating rooms, and training facilities that use 4K UHD cameras and display monitors for surgical operations and post-surgery reviews and research.
Read More
Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions